UY28291A1 - Inhibidores de la pde9 para tratar la diabetes tipo 2, síndrome metabólico y enfermedad cardiovascular - Google Patents
Inhibidores de la pde9 para tratar la diabetes tipo 2, síndrome metabólico y enfermedad cardiovascularInfo
- Publication number
- UY28291A1 UY28291A1 UY28291A UY28291A UY28291A1 UY 28291 A1 UY28291 A1 UY 28291A1 UY 28291 A UY28291 A UY 28291A UY 28291 A UY28291 A UY 28291A UY 28291 A1 UY28291 A1 UY 28291A1
- Authority
- UY
- Uruguay
- Prior art keywords
- diabetes
- cardiovascular disease
- metabolic syndrome
- treat type
- pde9 inhibitors
- Prior art date
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 2
- 208000001145 Metabolic Syndrome Diseases 0.000 title abstract 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title abstract 2
- 229940076380 PDE9 inhibitor Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000000651 prodrug Substances 0.000 abstract 2
- 229940002612 prodrug Drugs 0.000 abstract 2
- 208000032928 Dyslipidaemia Diseases 0.000 abstract 1
- 208000002705 Glucose Intolerance Diseases 0.000 abstract 1
- 208000017170 Lipid metabolism disease Diseases 0.000 abstract 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
- 201000009104 prediabetes syndrome Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invención proporciona los compuestos de fórmula (i) los estereoisómeros y los profármacos de los mismos, y las sales de los compuetos, estereoisómeros, y profármacos farmacéuticamente aceptables, en la que A, P, J, x y R10 son como se han definido en esta memoria descriptiva; las composiciones farmacéuticas de los mismos; y los procedimientos de uso de las composiciones farmacéuticas para el tratamiento de enfermedades, incluyendo diabetes, que incluye diabetes tipo 1 y tipo 2, hiperglucemia, dislipidemia, tolerancia a la glucosa alterada, síndrome metabólico, y/o enfermedad cardiovascular.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46663903P | 2003-04-30 | 2003-04-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY28291A1 true UY28291A1 (es) | 2004-11-30 |
Family
ID=33551403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY28291A UY28291A1 (es) | 2003-04-30 | 2004-04-27 | Inhibidores de la pde9 para tratar la diabetes tipo 2, síndrome metabólico y enfermedad cardiovascular |
Country Status (8)
| Country | Link |
|---|---|
| AR (1) | AR044119A1 (es) |
| CL (1) | CL2004000901A1 (es) |
| GT (1) | GT200400086A (es) |
| NL (1) | NL1026091C2 (es) |
| PA (1) | PA8601601A1 (es) |
| PE (1) | PE20050466A1 (es) |
| TW (1) | TW200503714A (es) |
| UY (1) | UY28291A1 (es) |
-
2004
- 2004-04-27 UY UY28291A patent/UY28291A1/es not_active Application Discontinuation
- 2004-04-27 PA PA20048601601A patent/PA8601601A1/es unknown
- 2004-04-27 PE PE2004000413A patent/PE20050466A1/es not_active Application Discontinuation
- 2004-04-28 AR ARP040101447A patent/AR044119A1/es unknown
- 2004-04-28 CL CL200400901A patent/CL2004000901A1/es unknown
- 2004-04-29 NL NL1026091A patent/NL1026091C2/nl not_active IP Right Cessation
- 2004-04-29 GT GT200400086A patent/GT200400086A/es unknown
- 2004-04-29 TW TW093112075A patent/TW200503714A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200503714A (en) | 2005-02-01 |
| PE20050466A1 (es) | 2005-06-18 |
| GT200400086A (es) | 2005-01-11 |
| AR044119A1 (es) | 2005-08-24 |
| CL2004000901A1 (es) | 2005-03-18 |
| PA8601601A1 (es) | 2005-02-04 |
| NL1026091C2 (nl) | 2005-05-26 |
| NL1026091A1 (nl) | 2004-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR8147A (es) | Derivados de pirido 2, 1a-isoquinolina, como inhibidores de dpp-iv | |
| UY28692A1 (es) | Nuevos derivados de quinolina | |
| HN2008001666A (es) | Derivados acidos de cicloalquilamino | |
| AR062841A1 (es) | Tratamiento del dolor, diabetes, y trastornos del metabolismo de los lipidos | |
| UY28135A1 (es) | Derivados de pirimidina para el tratamiento de crecimiento celular anormal | |
| MXPA05012573A (es) | Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de cinasa. | |
| ECSP067054A (es) | Nuevos derivados fluoroglicosídicos de pirazoles, medicamentos que contienen estos compuestos, y el empleo de los mismos | |
| PA8587101A1 (es) | Nuevos derivados de dihidropirimido [4,5-d] pirimidinona sustituida por amiino, fabricacion y uso de los mismos como agentes farmaceuticos | |
| ECSP066855A (es) | Derivados de benceno sustituidos por glucopiranosilo, medicamentos que contienen esos compuestos, su aplicación y procedimiento para su preparación | |
| ECSP088099A (es) | Nuevos derivados de la 2-azetidinona para el tratamiento de enfermedades hiperlipidémicas | |
| CR8744A (es) | Compuestos terapeuticos | |
| PA8622401A1 (es) | Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico,procesos para su preparacion y su uso como medicamentos | |
| ECSP066717A (es) | Compuestos de quinolina sustituidos | |
| UY28369A1 (es) | Agentes terapéuticos | |
| UY29246A1 (es) | Nuevos compuestos | |
| PA8680701A1 (es) | Derivados de oxindol | |
| CR9667A (es) | Derivados de benzamida y usos relacionados con los mismos | |
| ECSP088511A (es) | Agonistas del receptor del neuropeptido-2 | |
| UY29253A1 (es) | 3-amino-pirazol(3,4b)piridinas como inhibidores de proteintirosinquinasas, su preparación y uso como medicamento | |
| UY28923A1 (es) | Compuestos terapéuticos: piridina como estructura base | |
| UY28098A1 (es) | Derivados de anilinopirazol útiles en el tratamiento de la diabetes | |
| PA8568101A1 (es) | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso | |
| CO5611124A2 (es) | Derivados de benzofurano substituidos utiles en el tratamiento de desordenes hiper-proliferativos | |
| ECSP044994A (es) | Derivados de diarilcicloalquilo, procedimientos para su preparacion y su utilización como agentes activadores del ppar | |
| PA8514901A1 (es) | Metabolitos agonistas/antagonistas de estrogeno |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20150522 |